New Jersey / Glasgow (4thAugust 2022): Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma-marketers, has appointed industry sales and marketing veteran Mike Strassberg as Chief Customer Officer. As the Scottish company’s first US-based appointment, Mike is set to drive the data tech’s continued growth in the US.
Strassberg joins Talking Medicines having led sales and marketing at Eversana Intouch B2D for the last three years. With 30 years of experience in the health and life sciences industry Strassberg is ready to drive growth, build new relationships and help Talking Medicines establish its AI platform PatientMetRx® as the premier digital source of patient voice for medical marketers and agencies.
Based in New York, Mike will focus on new customer acquisition and will work closely with current customers to help them maximize the value of their platform subscriptions. Strassberg will draw from multiple leadership roles at top medical communication agencies management consultancies and pharma product marketing, to help Talking Medicines achieve its vision of becoming the world’s gold standard provider of patient intelligence.
Talking Medicines opened its New Jersey office earlier this year and has already secured contracts with a number of leading US-based medical advertising agencies.
Mike Strassberg, new Chief Customer Officer at Talking Medicines said: “Building a patient-centric commercial organization has become a necessity for life sciences companies, and by extension their marketing agencies, but until now there has been limited insight into actual patient experiences. The PatientMetRx® cloud-based software, powered by Talking Medicines’ AI enabled platform, provides a unique view of the patient voice, which can illuminate the patient perspective, delivering better health outcomes. It’s an exciting time to join the business, with the innovative Patient Opinion Mapping feature showcasing just how powerful the insights from the system can be. Several major marketing agencies have already subscribed to PatientMetRx® and I’m looking forward to driving further growth and building a US operation.”
Jo Halliday, Co-founder, and CEO of Talking Medicines said: “Just as Talking Medicines is the voice of patients, Mike will be the voice of our customers, providing a consistent and seamless experience, driving growth, establishing new relationships, managing current accounts, and building a global customer-centric organization. With extensive experience in the sector Mike will open doors for us and continue to expand our network. I am looking forward to collaborating closely with him as we enter an exciting phase in the growth of the business.”